NCT03192371View on ClinicalTrials.gov

A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 15, 2018

Primary Completion Date

May 12, 2019

Study Completion Date

May 12, 2019

Conditions
Virus Diseases
Interventions
BIOLOGICAL

Rabipur

Rabies vaccine administered as an intramuscular injection according to Zagreb or Essen regimen to subjects aged ≥6 to ≤17 years.

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03192371 - A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children | Biotech Hunter | Biotech Hunter